Status:
RECRUITING
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Conditions:
Post-bariatric Surgery
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
The overall goal of this project is to understand the mechanisms by which gastric bypass surgery improves glucose metabolism. The central hypothesis guiding this project is that the reconfiguration o...
Detailed Description
The overall goal of this project is to understand the mechanisms by which gastric bypass surgery improves glucose metabolism. The central hypothesis guiding this project is that the reconfiguration o...
Eligibility Criteria
Inclusion
- age 18-65
- healthy control without diabetes or active organ disease
- Individuals with bariatric surgery
- recurrent hypoglycemia post gastric bypass
Exclusion
- pregnancy
- significant anemia
- diabetes currently unless pre-op for bariatric surgery procedure
- GI obstruction
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01803451
Start Date
November 1 2005
End Date
August 1 2027
Last Update
September 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Diabetes Institute - University Health System
San Antonio, Texas, United States, 78207
2
South Texas Veterans Health Care System
San Antonio, Texas, United States, 78229